Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker Study.
Saved in:
| Title: | Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker Study. |
|---|---|
| Authors: | Wesolowski R; Stefanie Spielman Comprehensive Breast Center, The Ohio State University, Columbus, Ohio, USA.; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Stover DG; Stefanie Spielman Comprehensive Breast Center, The Ohio State University, Columbus, Ohio, USA.; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Lustberg MB; Stefanie Spielman Comprehensive Breast Center, The Ohio State University, Columbus, Ohio, USA., Shoben A; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Zhao M; Stefanie Spielman Comprehensive Breast Center, The Ohio State University, Columbus, Ohio, USA., Mrozek E; Mercy Health - St. Rita's Medical Center, Lima, Ohio, USA., Layman RM; University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Macrae E; Columbus Oncology, Columbus, Ohio, USA., Duan W; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Zhang J; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Hall N; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Wright CL; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Gillespie S; Stefanie Spielman Comprehensive Breast Center, The Ohio State University, Columbus, Ohio, USA., Berger M; Stefanie Spielman Comprehensive Breast Center, The Ohio State University, Columbus, Ohio, USA., Chalmers JJ; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Carey A; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Balasubramanian P; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Miller BL; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Amaya P; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Andreopoulou E; Weill Cornell Medicine, New York, New York, USA., Sparano J; Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA., Shapiro CL; Tisch Cancer Institute, Mt. Sinai Hospital, New York, New York, USA., Villalona-Calero MA; Miami Cancer Institute, Baptist Health South Florida, Miami, Florida, USA., Geyer S; University of South Florida, Tampa, Florida, USA., Chen A; National Cancer Institute, Bethesda, Maryland, USA., Grever MR; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Knopp MV; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Ramaswamy B; Stefanie Spielman Comprehensive Breast Center, The Ohio State University, Columbus, Ohio, USA. |
| Source: | The oncologist [Oncologist] 2020 Aug; Vol. 25 (8), pp. e1158-e1169. Date of Electronic Publication: 2020 Jun 17. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1549-490X |
|---|---|
| DOI: | 10.1634/theoncologist.2020-0039 |
